Invention Grant
US08440653B2 3-substituted-1,4-diazepan-2-one melanocortin-5 receptor antagonists
有权
3-取代-1,4-二氮杂环庚烷-2-酮黑皮质素-5受体拮抗剂
- Patent Title: 3-substituted-1,4-diazepan-2-one melanocortin-5 receptor antagonists
- Patent Title (中): 3-取代-1,4-二氮杂环庚烷-2-酮黑皮质素-5受体拮抗剂
-
Application No.: US12919973Application Date: 2009-02-27
-
Publication No.: US08440653B2Publication Date: 2013-05-14
- Inventor: Mark Arnold Thomas Blaskovich , Peter Joseph Cassidy
- Applicant: Mark Arnold Thomas Blaskovich , Peter Joseph Cassidy
- Applicant Address: AU Milton, Queensland
- Assignee: Mimetica Pty Ltd
- Current Assignee: Mimetica Pty Ltd
- Current Assignee Address: AU Milton, Queensland
- Agency: Knobbe, Martens, Olson & Bear, LLP
- International Application: PCT/AU2009/000232 WO 20090227
- International Announcement: WO2009/105825 WO 20090903
- Main IPC: C07D243/08
- IPC: C07D243/08 ; C07D401/06 ; C07D401/12 ; A61K31/551
Abstract:
The present invention provides compounds of Formula (I) that are useful for modulating the biological activity of the melanocortin-5 receptor (MC5R). Compounds of this invention can be used to treat diseases and/or conditions in which downregulation of MC5R is beneficial. Such diseases and/or conditions include, but are not limited to, acne, seborrhea, seborrheic dermatitis, cancer, and inflammatory diseases.
Public/Granted literature
- US20110059952A1 3-SUBSTITUTED-1,4-DIAZEPAN-2-ONE MELANOCORTIN-5 RECEPTOR ANTAGONISTS Public/Granted day:2011-03-10
Information query
